EPHB4 and Miyoshi myopathy: Along with the above-mentioned mechanisms, it has been shown that the deregulated expression of cell surface ligands and/or receptors involved in bone homeostasis or osteogenic signaling pathways in MM-MSCs (i.e., EphB4 and Ror2), negatively affects their OB differentiation and function.